We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Medlab Middle East Looks to The Future of Laboratories

By LabMedica International staff writers
Posted on 24 Jan 2025
Print article
Image: The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre (Photo courtesy of Informa Markets)
Image: The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre (Photo courtesy of Informa Markets)

The medical laboratory market in the Middle East and Africa (MEA) is expected to experience substantial growth, with projections indicating it could reach USD 473.84 million by 2029, growing at a strong Compound Annual Growth Rate (CAGR) of 12.6%. Against this promising backdrop, Medlab Middle East (Dubai, UAE), organized by Informa Markets (London, UK), will take place from February 3-6, 2024, in Dubai, UAE. This event will gather medical laboratory professionals and industry leaders to discuss the future of laboratories and their transformative impact on healthcare both regionally and globally. The 2025 edition of Medlab Middle East will focus on the theme "Empowering today’s medical labs for tomorrow’s global future." Key product categories showcased will include disposable products, medical equipment, IT, pharma/nutrition, and lab services. Medlab Middle East 2024 generated an impressive USD 670 million in business, reinforcing its significance in the global healthcare sector.

Medical laboratories play a vital role in the healthcare system, providing diagnostic and testing services that are critical for disease identification, monitoring, and treatment decisions. With an increasing prevalence of chronic and non-communicable diseases, a growing population, and mandatory healthcare and insurance coverage in the MEA region, the demand for medical laboratory services has surged. Technologies in medical labs enhance the ability to collect and analyze patient health data, leading to more accurate, personalized diagnoses and treatment, ultimately improving patient outcomes, reducing costs, and increasing accessibility.

Recent technological advances have significantly improved healthcare, with key innovations including Next-Generation Sequencing (NGS), Point-of-Care Testing (POCT), and 3D Printing. Artificial Intelligence (AI) and machine learning are also making their mark in medical lab technology, enabling data analytics and predictive algorithms to improve diagnoses and patient care. At Medlab Middle East, global laboratory leaders such as Abbott, Beckman Coulter, Randox, and Sansure will showcase their latest innovations. Sansure will present the IPonatic III Pro, a POCT solution that utilizes magnetic extraction technology to overcome the limitations of traditional PCR methods and offer fast, reliable results.

Beckman Coulter will display the DxC 500 AU Chemistry Analyzer to optimize lab operations and the Dxl 9000 Access Immunoassay Analyzer to meet increased diagnostic demand. Randox will unveil the Acusera Smart Range, which simplifies stock management, reduces inventory, and saves time for laboratories. The Medlab Middle East Congress will feature over 150 world-class speakers and offer 12 CME-accredited conference tracks covering topics like Lab Management, Clinical Chemistry, Hematology, Clinical Microbiology, Molecular Diagnostics, and more. New this year, Thought Leadership Forums will focus on Women’s Health and Precision Medicine. The Global Lab Leaders Breakfast Forum, set for days two and three of the event, will bring together experts and stakeholders to drive advancements in laboratory practices globally.

“Now in its 24th edition, Medlab Middle East showcases the forefront of laboratory technology and innovation, attracting global leaders, pioneers, and industry experts,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “The event offers a premier platform for experiencing groundbreaking discoveries, exploring cutting-edge solutions, and engaging in invaluable networking opportunities.”

Related Links:
Medlab Middle East
Informa Markets

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Refrigerated Centrifuge
CAPPRondo Refrigerated Centrifuge
New
Urine Drug Test
Instant-view Propoxyphene Urine Drug Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Low levels of a protein that signals placental development could alert physicians to the need for enhanced monitoring (Photo courtesy of Shutterstock)

Blood Test Could Identify Expectant Mothers at Risk of Preterm Delivery

Early preterm birth, defined as delivery before 34 weeks of gestation, carries significant risks for adverse health outcomes. However, there is no universal screening strategy available, which limits the... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.